Dosidal · Switzerland

Akynzeo IV, Konzentrat zur Herstellung einer Infusionslösung

Dosidal is a product record. It identifies a medicine and its regulatory status. It does not advise on use.

MarketSwitzerland
Recordch:authorisation:68290 (version 1)
Levelauthorisation
Pack codenot anchored
Identifiersswissmedic-authorisation: 68290
atc: A04AA55
Source authoritySwissmedic
Read date
authorisation statusfirst_authorisation: 2022-09-01
term: zugelassen
valid_until: 9999-12-31
state: current · read 2026-11-15T01:25:13Z · source: Swissmedic (OGD) page
identityatc: A04AA55
authorisation_number: 68290
form: KOINF
holder: Medius AG
holder_partner_nr: 1000971
it_number: 01.09.0.
name: Akynzeo IV, Konzentrat zur Herstellung einer Infusionslösung
state: current · read 2026-11-15T01:25:13Z · source: Swissmedic (OGD) page
SignatureES256 over JCS, key dosidal-record-1.9dbf5d53
BidGpoMImtjQx0pyvhadUozT_cX9sc1LPkaz9OB1edJ7Wht-EoDhD7SvbtuT4F90RU8bnxkmLKw2UAIkgkfJOg
Verify with verify_record (MCP) or POST https://dosidal-api.ai/v1/verify/record; keyring https://dosidal-registry.ai/.well-known/jwks.json

JSON: https://dosidal-api.ai/v1/records/ch:authorisation:68290 · Related records in other markets · Dosidal